Polymarket
Another US debt downgrade before 2027?
Another US debt downgrade before 2027?
BLK · NYSE
strong_buy · 12 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 17, 2026 | BMO Capital | Maintains | Outperform | $1,300.00 |
| July 16, 2026 | UBS | Maintains | Buy | $1,320.00 |
| July 16, 2026 | Evercore ISI Group | Maintains | Outperform | $1,245.00 |
| July 16, 2026 | Morgan Stanley | Maintains | Overweight | $1,488.00 |
| July 16, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,300.00 |
| July 16, 2026 | B of A Securities | Maintains | Buy | $1,320.00 |
| July 16, 2026 | Barclays | Maintains | Overweight | $1,450.00 |
| July 16, 2026 | JP Morgan | Upgrades | Overweight | $1,364.00 |
| July 14, 2026 | Morgan Stanley | Maintains | Overweight | $1,383.00 |
| July 10, 2026 | Evercore ISI Group | Maintains | Outperform | $1,145.00 |
| July 10, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,275.00 |
| July 9, 2026 | Barclays | Maintains | Overweight | $1,340.00 |
| June 26, 2026 | Morgan Stanley | Maintains | Overweight | $1,430.00 |
| April 15, 2026 | UBS | Maintains | Buy | $1,270.00 |
| April 15, 2026 | Morgan Stanley | Maintains | Overweight | $1,393.00 |
| April 15, 2026 | Goldman Sachs | Maintains | Buy | $1,313.00 |
| April 15, 2026 | Evercore ISI Group | Maintains | Outperform | $1,220.00 |
| April 15, 2026 | Barclays | Maintains | Overweight | $1,310.00 |
| April 15, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,240.00 |
| April 13, 2026 | JP Morgan | Maintains | Neutral | $1,128.00 |
| April 10, 2026 | Evercore ISI Group | Maintains | Outperform | $1,180.00 |
| April 10, 2026 | BMO Capital | Maintains | Outperform | $1,200.00 |
| April 9, 2026 | UBS | Maintains | Buy | $1,235.00 |
| April 8, 2026 | Barclays | Maintains | Overweight | $1,290.00 |
| April 7, 2026 | Goldman Sachs | Maintains | Buy | $1,181.00 |
| April 1, 2026 | Morgan Stanley | Maintains | Overweight | $1,368.00 |
| February 23, 2026 | UBS | Upgrades | Buy | $1,280.00 |
| January 23, 2026 | Freedom Broker | Upgrades | Buy | $1,364.00 |
| January 16, 2026 | UBS | Maintains | Neutral | $1,280.00 |
| January 16, 2026 | Barclays | Maintains | Overweight | $1,350.00 |
| January 16, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,340.00 |
| January 14, 2026 | TD Cowen | Downgrades | Hold | $1,209.00 |
| January 12, 2026 | UBS | Maintains | Neutral | $1,218.00 |
| January 8, 2026 | Barclays | Maintains | Overweight | $1,300.00 |
| January 8, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,310.00 |
| December 17, 2025 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,322.00 |
| December 17, 2025 | Morgan Stanley | Maintains | Overweight | $1,514.00 |
| December 12, 2025 | Barclays | Maintains | Overweight | $1,340.00 |
| October 21, 2025 | Freedom Broker | Maintains | Hold | $1,255.00 |
| October 15, 2025 | Barclays | Maintains | Overweight | $1,360.00 |
| October 15, 2025 | TD Cowen | Maintains | Buy | $1,407.00 |
| October 15, 2025 | Morgan Stanley | Maintains | Overweight | $1,486.00 |
| October 15, 2025 | B of A Securities | Maintains | Buy | $1,456.00 |
| October 13, 2025 | Keefe, Bruyette & Woods | Maintains | Outperform | $1,300.00 |
| October 9, 2025 | Evercore ISI Group | Maintains | Outperform | $1,230.00 |
| October 8, 2025 | Barclays | Maintains | Overweight | $1,310.00 |
| October 6, 2025 | Goldman Sachs | Maintains | Buy | $1,312.00 |
| October 6, 2025 | Morgan Stanley | Maintains | Overweight | $1,362.00 |
| October 2, 2025 | B of A Securities | Maintains | Buy | $1,396.00 |
| September 29, 2025 | Citigroup | Maintains | Buy | $1,350.00 |
| September 5, 2025 | Evercore ISI Group | Maintains | Outperform | $1,200.00 |
Live event probabilities associated with this company or market.
Polymarket
Another US debt downgrade before 2027?
BlackRock's aggressive push into private markets, targeting $400 billion in fundraising by 2030, combined with acquisitions like HPS and Preqin, positions the firm for sustained AUM growth. Morgan Stanley, Goldman Sachs, and Evercore ISI raised price targets in mid-April, reflecting strong confidence in this diversification strategy.
The integration of HPS and Preqin introduces meaningful execution risk and cost structure pressures. JPMorgan and TD Cowen lowered their targets, cautioning that high valuation multiples may not be sustainable if private market fundraising falls short or margin expansion from integrations is delayed.
BlackRock's earnings grew 2.7% over the past year, slightly above its five-year annualized pace of 2.6%, demonstrating consistent and durable profitability. The optimistic case rests on earnings quality and stability rather than requiring a sharp acceleration, with analysts maintaining an average price target of $1,315.93 implying ~20% upside.
BlackRock's revenue is forecast to grow 8.6% per year — well below the US market forecast of 12.8% — while earnings growth of ~11% annually lags the broader market's ~18%. Net profit margin has compressed to 24.1% from 29.7% a year earlier, raising concerns about the sustainability of its premium valuation.
BlackRock trades at a trailing P/E of 25.6x, well below the US Capital Markets industry average of 40x, and its current share price sits only ~3.1% below its DCF fair value of $1,121.29. With 17 Buy ratings and 0 Sells among 19 covering analysts, the consensus view is that the stock offers meaningful upside at current levels.
Despite trading at a discount to the broader industry, BlackRock's 25.6x P/E sits at a premium to its direct peer average of 18.4x, while margins have deteriorated significantly. Technical indicators, including an overbought RSI and a bearish MACD signal, suggest the stock may be due for a near-term pullback or consolidation.